[
    [
        {
            "time": "2021-01-27",
            "original_text": "泰格医药：预计2020年净利润同比增长100%-115%",
            "features": {
                "keywords": [
                    "泰格医药",
                    "净利润",
                    "同比增长",
                    "100%",
                    "115%"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "CRO行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "泰格医药：预计2020年净利润同比增长100%-115%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-01-27",
            "original_text": "【权益变动】泰格医药(03347-HK)被贝莱德减持24.82万股 减持股份",
            "features": {
                "keywords": [
                    "泰格医药",
                    "贝莱德",
                    "减持",
                    "24.82万股"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "CRO行业"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【权益变动】泰格医药(03347-HK)被贝莱德减持24.82万股 减持股份",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-01-27",
            "original_text": "万联证券-CRO行业深度报告：创新药大时代，CRO乘风起舞【行业研究】",
            "features": {
                "keywords": [
                    "CRO行业",
                    "创新药",
                    "深度报告",
                    "万联证券"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "CRO行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "万联证券-CRO行业深度报告：创新药大时代，CRO乘风起舞【行业研究】",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-01-27",
            "original_text": "高瓴资本概念股走势分化，国瓷材料、健帆生物、泰格医药均下滑",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "泰格医药",
                    "下滑",
                    "国瓷材料",
                    "健帆生物"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "CRO行业"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "高瓴资本概念股走势分化，国瓷材料、健帆生物、泰格医药均下滑",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-01-27",
            "original_text": "港股异动︱泰格医药(03347)跌超6% 遭FIDELITY INVESTMENT TRUST减持17.4万股 共涉资约3119.13万元 减持股份数量",
            "features": {
                "keywords": [
                    "泰格医药",
                    "港股",
                    "异动",
                    "FIDELITY INVESTMENT TRUST",
                    "减持",
                    "17.4万股"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "CRO行业"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "港股异动︱泰格医药(03347)跌超6% 遭FIDELITY INVESTMENT TRUST减持17.4万股 共涉资约3119.13万元 减持股份数量",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-01-27",
            "original_text": "中信建投：节前看好年报行情及疫情受益主线",
            "features": {
                "keywords": [
                    "中信建投",
                    "年报行情",
                    "疫情受益",
                    "节前"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "CRO行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "中信建投：节前看好年报行情及疫情受益主线",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]